Tuesday, 30 April 2019

A promising new treatment for infants with Noonan syndrome

Noonan Syndrome (NS) is a rare genetic syndrome typically evident at birth and often linked to early-onset severe heart disease. NS is part of a group of diseases termed RASopathies that are caused by activating mutations of proteins belonging to the Ras and mitogen-activated protein kinase families.

* This article was originally published here